Close Menu
Home » RareCyte Raises $22M in Financing Round

RareCyte Raises $22M in Financing Round

Dec 19, 2019
|
staff reporter

NEW YORK – Rare cell analysis firm RareCyte said on Thursday that is has raised $22 million from new and existing investors.

The financing was led by HealthQuest Capital, with participation from 5AM Ventures and RareCyte founder Ron Seubert.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Letter Condemns Virus Conspiracy Theories

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

Philip Leder Dies

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

New and Maybe Important

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

Nucleic Acids Research Studies on Alu Genotyping, Stress Response Histones, Undocumented Small RNAs

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.

What's Popular?

In Sample Prep

  1. 10x Genomics Previews New Product Lineup Ahead of AGBT

    Premium

  2. S2 Genomics, Riken Partner on Single-Cell Genomics Applications

  3. Bio-Rad Laboratories Products Indirectly Infringe 10x Genomics Patents, USITC Confirms

  4. Genetron Health Obtains Regulatory Approval in China for NGS Instrument, Lung Cancer Panel

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.